Xiang Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiang Huang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Daifeng Wang
Waisman Center, University of Wisconsin-Madison, Madison, USA
3 shared publications - Athan Z. Li
Department of Computer Science, University of Southern California, Los Angeles, CA 90089, USA
2 shared publications Chirag Gupta
Waisman Center, University of Wisconsin-Madison, Madison, WI, USA
2 shared publications- Donghoon Lee
Icahn School of Medicine at Mount Sinai
2 shared publications - Gabriel E. Hoffman
Icahn School of Medicine at Mount Sinai
2 shared publications - Georgios Voloudakis
Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, USA
2 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (10) , 3682-3694
AI-based characterization of Alzheimer’s disease phenotypes from population-scale single-cell data
The complexity of Alzheimer’s disease (AD) manifests in diverse clinical phenotypes, including cognitive impairment and neuropsychiatric symptoms. However, the etiology of these phenotypes remains elusive. To address this, the PsychAD project generated a population-level single-nucleus RNA sequencing dataset comprising over 6 million nuclei from the prefrontal cortex of >1,000 individual brains, covering a variety of disease phenotypes. Here, leveraging this dataset, we developed a computational framework, called Phenotype Associated Single Cell encoder (PASCode), to score single-cell phenotype associations, and identified ∼1.5 million phenotype-associated cells (PACs) from 584 donors with AD-related phenotypes. PASCode ensembles multiple statistical methods into a graph neural model for robust scoring. Comparing PACs within 27 brain cell subclasses, we prioritized cell subpopulations and their expressed genes for various AD phenotypes. For instance, we identified microglia subpopulations implicated in AD pathology; reactive astrocyte subtypes with altered neuroprotective and neurotoxic gene expression that likely confer cognitive resilience; and enhanced excitatory/inhibitory imbalance and mitochondrial dysfunction in cognitively impaired AD donors. We also identified many PACs for multiple phenotypes, including the astrocytes between AD and depression showing specific gene expression patterns such as inflammation and endoplasmic reticulum stress pathways. These prioritized subpopulations, genes and pathways potentially offer valuable insights for precision diagnostic and therapeutic development. We also validated our findings in external population-scale datasets including AD and major depressive disorder, compiled an AD-phenotypic single-cell atlas and delivered the framework as an open-source tool with pre-trained models and a web application for community use.
- 23 September 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (10) , 3682-3694
Open AccessAI-based characterization of Alzheimer’s disease phenotypes from population-scale single-cell data
The complexity of Alzheimer’s disease (AD) manifests in diverse clinical phenotypes, including cognitive impairment and neuropsychiatric symptoms. However, the etiology of these phenotypes remains elusive. To address this, the PsychAD project generated a population-level single-nucleus RNA sequencing dataset comprising over 6 million nuclei from the prefrontal cortex of >1,000 individual brains, covering a variety of disease phenotypes. Here, leveraging this dataset, we developed a computational framework, called Phenotype Associated Single Cell encoder (PASCode), to score single-cell phenotype associations, and identified ∼1.5 million phenotype-associated cells (PACs) from 584 donors with AD-related phenotypes. PASCode ensembles multiple statistical methods into a graph neural model for robust scoring. Comparing PACs within 27 brain cell subclasses, we prioritized cell subpopulations and their expressed genes for various AD phenotypes. For instance, we identified microglia subpopulations implicated in AD pathology; reactive astrocyte subtypes with altered neuroprotective and neurotoxic gene expression that likely confer cognitive resilience; and enhanced excitatory/inhibitory imbalance and mitochondrial dysfunction in cognitively impaired AD donors. We also identified many PACs for multiple phenotypes, including the astrocytes between AD and depression showing specific gene expression patterns such as inflammation and endoplasmic reticulum stress pathways. These prioritized subpopulations, genes and pathways potentially offer valuable insights for precision diagnostic and therapeutic development. We also validated our findings in external population-scale datasets including AD and major depressive disorder, compiled an AD-phenotypic single-cell atlas and delivered the framework as an open-source tool with pre-trained models and a web application for community use.
- Open Access
- 23 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9596
Personalized single-cell transcriptomics reveals molecular diversity in Alzheimer’s disease
Alzheimer’s disease (AD) is highly heterogeneous and driven by diverse molecular and cellular mechanisms. Functional genomics investigates these mechanisms from genetic variants to gene expression and regulation. We performed personalized functional genomics analysis on population-scale single-nucleus RNA-seq data, with cross-cohort validation across multiple cohorts comprising over 1900 individual brains, capturing donor-level cell type interactions and gene regulatory networks. Using a knowledge-guided graph neural network, we learned latent representations of each donor’s functional genomics that accurately classified AD phenotypes, identified molecularly defined subpopulations, and traced disease progression trajectories. Our importance scores, derived from graph attentions, identified significant inter-donor differences and prioritized personalized cell type genes and regulatory networks. Finally, we identified gene regulatory QTLs (grQTLs) linking genetic variants to donor-level regulatory changes, providing insights into gene regulatory relationships beyond traditional eQTLs. All results are summarized into a personalized functional genomics atlas for AD, including an open-source framework, iBrainMap, for general use.
- 23 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9596
Open AccessPersonalized single-cell transcriptomics reveals molecular diversity in Alzheimer’s disease
Alzheimer’s disease (AD) is highly heterogeneous and driven by diverse molecular and cellular mechanisms. Functional genomics investigates these mechanisms from genetic variants to gene expression and regulation. We performed personalized functional genomics analysis on population-scale single-nucleus RNA-seq data, with cross-cohort validation across multiple cohorts comprising over 1900 individual brains, capturing donor-level cell type interactions and gene regulatory networks. Using a knowledge-guided graph neural network, we learned latent representations of each donor’s functional genomics that accurately classified AD phenotypes, identified molecularly defined subpopulations, and traced disease progression trajectories. Our importance scores, derived from graph attentions, identified significant inter-donor differences and prioritized personalized cell type genes and regulatory networks. Finally, we identified gene regulatory QTLs (grQTLs) linking genetic variants to donor-level regulatory changes, providing insights into gene regulatory relationships beyond traditional eQTLs. All results are summarized into a personalized functional genomics atlas for AD, including an open-source framework, iBrainMap, for general use.
- Top Cited Papers
- 23 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6796) , eaea1549
Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex
Down syndrome is a genetic condition that causes intellectual disability and is characterized by early-onset delays in motor, cognitive, and language development. The molecular mechanisms underlying these neurodevelopmental impairments remain poorly understood. We used single-nucleus multiomic sequencing to simultaneously profile gene expression and chromatin accessibility in the Down syndrome prefrontal cortex during early postnatal development, a critical period for synaptogenesis, neural maturation, and developmental neuroimmune interactions. Our findings reveal widespread dysregulation of chromatin accessibility and gene expression, with deficits spanning metabolic and synaptic pathways, oligodendrocyte lineage progression, and a pronounced neuroinflammatory signature. We present a molecular atlas of Down syndrome neuropathology at a critical stage of brain development, highlighting convergent neurodevelopmental and neurodegenerative pathways and informing potential targeted therapies for Down syndrome–associated neuroinflammation.
- 23 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6796) , eaea1549
Top Cited PapersMolecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex
Down syndrome is a genetic condition that causes intellectual disability and is characterized by early-onset delays in motor, cognitive, and language development. The molecular mechanisms underlying these neurodevelopmental impairments remain poorly understood. We used single-nucleus multiomic sequencing to simultaneously profile gene expression and chromatin accessibility in the Down syndrome prefrontal cortex during early postnatal development, a critical period for synaptogenesis, neural maturation, and developmental neuroimmune interactions. Our findings reveal widespread dysregulation of chromatin accessibility and gene expression, with deficits spanning metabolic and synaptic pathways, oligodendrocyte lineage progression, and a pronounced neuroinflammatory signature. We present a molecular atlas of Down syndrome neuropathology at a critical stage of brain development, highlighting convergent neurodevelopmental and neurodegenerative pathways and informing potential targeted therapies for Down syndrome–associated neuroinflammation.
- 1 February 2021
- Published by Elsevier in Journal of Power Sources
- Vol. 484
Spatially-resolved lithiation dynamics from operando X-ray diffraction and electrochemical modeling of lithium-ion cells
- 1 February 2021
- Published by Elsevier in Journal of Power Sources
- Vol. 484
Spatially-resolved lithiation dynamics from operando X-ray diffraction and electrochemical modeling of lithium-ion cells